Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study
Jae-Hyun Lim, You-Jung Choi, Bong Sung Kim, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate Cardiovascular Risk in Patients With Diabetes
FNU Jyotsna, Areeba Ahmed, Kamal Kumar, et al.
Cureus (2023)
Open Access | Times Cited: 75
Efficacy and prognosis of dapagliflozin in the treatment of patients with acute myocardial infarction complicated with type 2 diabetes in Xining area
Jinping Chai, Delian Li, Yanmin Liu, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Clinical outcomes according to the average daily dose of sacubitril/valsartan: a nationwide longitudinal cohort study
Jae-Hyun Lim, Hyun‐Jung Lee, Soongu Kwak, et al.
Clinical Research in Cardiology (2025)
Open Access
Response by Bonnesen et al to Letter Regarding Article, “Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation”
Kasper Bonnesen, Uffe Heide‐Jørgensen, Morten Schmidt
Circulation (2025) Vol. 151, Iss. 17
Closed Access
Letter by Dong et al Regarding Article, “Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation”
Jiayang Dong, Xinyue Yang, Wenjuan Zhang
Circulation (2025) Vol. 151, Iss. 17
Closed Access
Comparative Cardiovascular Outcomes of Dapagliflozin Versus Empagliflozin in Patients With Type 2 Diabetes: A Meta-Analysis
Rhuna Dhana, Yousef H Aqel, Anurag Rawat, et al.
Cureus (2025)
Open Access
Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus
J. J. Kim, Young‐Chae Yoon, Young‐Hoon Kim, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 3
Open Access | Times Cited: 2
Prescription Trends on the Preference of Hypoglycemic Agents for the Management of Diabetes Mellitus in India
S Manjula, Krishna Kumar M
South Asian Research Journal of Medical Sciences (2024) Vol. 6, Iss. 01, pp. 14-19
Open Access | Times Cited: 1
Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Acute Coronary Syndrome
Jiawei Song, Yan Liu, Yani Xu, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 6, pp. 1847-1855
Open Access | Times Cited: 1
The Comparison of the Effectiveness of Dapagliflozin and Empagliflozin in the Prevention of Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Network Meta-Analysis
Tanya Sinha, Ushna Gul, Nawabzada Nadir Babar, et al.
Cureus (2024)
Open Access
Empagliflozin improves aortic injury in obese mice by regulating fatty acid metabolism
Lin Yue, Yue Wang, Cuiying Wang, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access
Mortality and Hospitalization Rate of Heart Failure Patients with Preserved Ejection Fraction Treated with Dapagliflozin vs. Empagliflozin
J. Tam, Franco Wing Tak Cheng, A. So
Research in Clinical Pharmacy (2023) Vol. 1, Iss. 2, pp. 127-136
Open Access
Page 1

Scroll to top